Yangzhou, China Clinical Trials

A listing of Yangzhou, China clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 17 clinical trials
A Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FLT3 Mutation

The purpose of this study is to determine the clinical benefit of ASP2215 therapy in participants with FMS-like tyrosine kinase (FLT3) mutated AML who are refractory to or have relapsed after first-line AML therapy as shown with overall survival (OS) compared to salvage chemotherapy. In addition, this study will evaluate …

Site CN126
 (0.0 away) Contact site
  • 242 views
  • 26 Oct, 2020
  • +52 other locations
Study of Durvalumab + Tremelimumab Durvalumab and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

This is a Phase III, Randomized, Double-blind, Placebo-controlled, Multi-center, International Study of Durvalumab or Durvalumab and Tremelimumab as Consolidation Treatment for Patients with LS-SCLC Who Have Not Progressed Following Concurrent Chemoradiation Therapy

chemoradiotherapy
cancer chemotherapy
prophylactic cranial irradiation
limited stage small cell lung cancer
etoposide
Research Site
 (2.0 away) Contact site
  • 268 views
  • 26 Nov, 2020
  • +217 other locations
Efficacy and Safety Study of Dupilumab in Patients With Persistent Asthma

Primary Objective: To evaluate the efficacy of dupilumab in patients with persistent asthma Secondary Objectives: To evaluate the safety and tolerability of dupilumab To evaluate the effect of dupilumab on improving patient reported outcomes including health related quality of life To evaluate dupilumab systemic exposure and immunogenicity

prednisone
bronchodilator
fractional exhaled nitric oxide
eosinophil count
nitric oxide
Investigational Site Number 1560055
 (2.0 away) Contact site
  • 128 views
  • 04 Oct, 2020
  • +64 other locations
Ezetimibe (EZ)/Atorvastatin (Ator) (MK-0653C) vs. Ator in Chinese Hypercholesterolemic Participants (MK-0653C-439)

This study will evaluate the EZ/Ator fixed-dose combination (FDC) tablet (MK-0653C) as second line Low-Density Lipoprotein - Cholesterol (LDL-C) treatment in Chinese participants. The primary hypothesis is that MK-0653C 10/10 mg is superior to atorvastatin 20 mg in percent change from baseline in LDL-C to 12 weeks after treatment.

dyslipidemia
atorvastatin
low density lipoprotein
ezetimibe
Subei People's Hospital ( Site 0040)
 (2.0 away) Contact site
  • 17 views
  • 25 Nov, 2020
  • +31 other locations
A Clinical Trial to Compare the Efficacy and Safety of 1-week Treatment of Intravenous N-acetylcysteine (NAC) 600 mg Twice Daily Ambroxol Hydrochloride 30 mg Twice Daily and Placebo as Expectorant Therapies in Adult Chinese Patients With Respiratory Tract Diseases and Abnormal Mucus Secretions

This is a phase 3, multicenter, randomized, rater- and patient-blind, placebo- and active-controlled, 3-arm parallel group clinical trial. Patients will be randomized to N-acetylcysteine (NAC) or ambroxol or placebo in a 1:1:1 ratio. A total of approximately 333 patients in China will be randomized. The total study duration will be …

bronchitis
cystic fibrosis
bronchiectasis
ambroxol
Yangzhou First People's Hospital
 (0.0 away) Contact site
  • 4 views
  • 21 Oct, 2020
  • +37 other locations
Study to Evaluate Tezepelumab in Adults With Severe Uncontrolled Asthma

A Regional, Multicentre, Randomized, Double-Blind, Placebo Controlled, Parallel Group, Phase 3 Study to Evaluate the Efficacy and Safety of Tezepelumab in Adults with Severe Uncontrolled Asthma

albuterol
fluticasone
Research Site
 (2.0 away) Contact site
  • 29 views
  • 11 Nov, 2020
  • +49 other locations
Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis

This is a 6 month study investigating the effectiveness and safety of tofacitinib in treating signs and symptoms and improving physical function in Chinese patients with active psoriatic arthritis and had inadequate response to a conventional synthetic disease modifying anti-rheumatic drug. This is a China alone study.

plaque psoriasis
psoriasis
arthritis
tofacitinib
rheumatic diseases
Department of Rheumatology, Northern Jiangsu People's Hospital
 (2.0 away) Contact site
  • 16 views
  • 11 Nov, 2020
  • +43 other locations